2m 2m 2m 2m 2m 2m 2m
PetMed Express (PETS)
NASDAQ
$1.81+$0.03 (+1.46%)
Price as of Jun 03, 2026 7:25 PM EDT- $46.4MMarket Cap
- -54.82%1-Year Change
- Pharmaceutical RetailersIndustry
PetMed Express (PETS)
$1.81+$0.03 (+1.46%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 227.0M -19.25% | 281.1M +9.54% | 256.6M -6.16% | 273.4M -11.58% | |
Cost of Revenue | 157.8M -22.02% | 202.4M +8.92% | 185.8M -4.86% | 195.3M -10.91% | |
Gross Profit | 69.1M -12.09% | 78.6M +11.19% | 70.7M -9.40% | 78.1M -13.20% | |
Sales and Marketing Expense | 23.8M -2.97% | 24.5M +26.17% | 19.4M +3.32% | 18.8M -13.13% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 7.0M -0.24% | 7.1M +98.98% | 3.5M +29.51% | 2.7M +12.81% | |
Total Operating Expenses | 70.7M -18.60% | 86.8M +34.21% | 64.7M +23.52% | 52.4M +0.010% | |
Operating Profit | -1.5M -81.25% | -8.2M -234.89% | 6.1M -76.46% | 25.7M -31.60% | |
Interest Income | N/A N/A | N/A N/A | 2.1M +517.91% | 335,000 +6.69% | |
Interest Expense | N/A N/A | N/A N/A | -1.6M N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 -100.00% | 450,000 +34.33% | 335,000 +6.69% | |
Total Nonoperating Income and Expense | 943,000 -50.08% | 1.9M +35.51% | 1.4M +2.42% | 1.4M -16.45% | |
Income before Taxes | -587,000 -90.64% | -6.3M -184.26% | 7.4M -72.50% | 27.1M -30.97% | |
Income Taxes | 5.7M +377.25% | 1.2M -48.33% | 2.3M -61.40% | 6.0M -30.67% | |
Extraordinary Items | 1.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -6.3M -15.98% | -7.5M -245.21% | 5.1M -75.64% | 21.1M -31.05% | |
Net Income from Continuing Operations Applicable to Common | -587,000 -90.64% | -6.3M -184.26% | 7.4M -72.50% | 27.1M -30.97% | |
Basic EPS and Net Income | -0.30 -18.92% | -0.37 -248.00% | 0.25 -76.19% | 1.05 -31.37% | |
Diluted EPS and Net Income | -0.30 -18.92% | -0.37 -248.00% | 0.25 -75.96% | 1.04 -31.58% | |
Basic Weighted Average Shares | 20.6M +0.98% | 20.4M +0.60% | 20.3M +0.49% | 20.2M +0.58% | |
Diluted Weighted Average Shares | 20.6M +0.98% | 20.4M +0.28% | 20.3M -0.09% | 20.4M +1.19% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 54.7M -1.04% | 55.3M -46.87% | 104.1M -6.30% | 111.1M -6.43% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 54.7M -1.04% | 55.3M -46.87% | 104.1M -6.30% | 111.1M -6.43% | |
Total Current Assets | 78.9M -15.78% | 93.6M -28.20% | 130.4M -13.62% | 151.0M -6.32% | |
Accumulated Depreciation | 25.2M +25.25% | 20.1M +32.15% | 15.2M +30.35% | 11.7M +13.14% | |
Property and Plant and Equipment and Net | 28.9M +8.26% | 26.7M +1.83% | 26.2M +7.01% | 24.5M -3.87% | |
Total Long-Term Assets | 69.8M -8.40% | 76.2M +105.78% | 37.0M +46.29% | 25.3M -3.75% | |
Total Assets | 148.7M -12.47% | 169.9M +1.44% | 167.5M -5.01% | 176.3M -5.96% | |
Income Taxes Payable | 25.2M +0.79% | 25.0M -4.22% | 26.1M +2,689.85% | 936,000 -26.93% | |
Total Short-Term Debt | N/A N/A | N/A N/A | 260,000 0.00% | 260,000 0.00% | |
Total Current Liabilities | 62.8M -13.01% | 72.2M +25.47% | 57.5M +73.24% | 33.2M -26.12% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.1M +6.63% | 995,000 N/A | 0 -100.00% | 1.9M -26.93% | |
Total Liabilities | 63.6M -13.11% | 73.2M +27.20% | 57.5M +68.49% | 34.1M -26.14% | |
Retained Earnings | 66.5M -7.00% | 71.6M -21.93% | 91.7M -29.76% | 130.5M -2.72% | |
Total Stockholders Equity | 85.1M -11.99% | 96.7M -12.04% | 110.0M -22.66% | 142.2M +0.64% | |
Total Shares Outstanding | 20.7M -2.33% | 21.1M +0.31% | 21.1M +0.50% | 21.0M +3.50% | |
Cash Flow | |||||
Cash from Operating Activities | 4.7M +9.29% | 4.3M -84.47% | 27.8M +50.30% | 18.5M -53.84% | |
Capital Expenditures | 5.1M +13.35% | 4.5M -14.24% | 5.3M +200.23% | 1.8M -27.96% | |
Cash from Investing Activities | -5.1M -87.43% | -40.7M +296.39% | -10.3M +485.62% | -1.8M -27.96% | |
Dividends Paid | 181,000 -98.54% | 12.4M -49.31% | 24.5M +0.63% | 24.4M +7.48% | |
Cash from Financing Activities | -181,000 -98.54% | -12.4M -49.31% | -24.5M +0.63% | -24.4M +7.48% | |
Financials Ratio | |||||
Gross Margin | 30.46% +8.86% | 27.98% +1.50% | 27.57% -3.46% | 28.56% -1.83% | |
Operating Margin | -0.67% -76.79% | -2.90% -223.14% | 2.36% -74.92% | 9.40% -22.64% | |
Return on Assets | -3.94% -11.03% | -4.42% -247.99% | 2.99% -74.22% | 11.60% -35.03% | |
Return on Equity | -6.90% -4.51% | -7.22% -277.15% | 4.08% -72.61% | 14.89% -34.01% | |
Revenue Growth | -19.25% -301.67% | 9.54% +254.96% | -6.16% -46.81% | -11.58% -231.10% | |
Current Ratio | 1.26 -3.18% | 1.30 -42.78% | 2.27 -50.14% | 4.55 +26.80% | |
Cash Ratio | 0.87 +13.77% | 0.77 -57.66% | 1.81 -45.91% | 3.35 +26.65% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow